NIH-funded research R01 grant

Effects of morphine and HIV proteins on brain function and behavior.

Official title: Impacts of morphine and HIV-Tat exposures and dimethylfumarate treatment on brain BDNF and mitochondrial and behavioral dysfunction.

Funded at University of Florida · NIH-11012305 · Data updated 2026-11-12

This study is looking at how morphine and HIV proteins influence brain health and behavior in people who have both opioid use disorder and HIV, with the hope of finding better ways to help them feel better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startApril 1, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$665,637
NIH project number5R01DA055568-03
Project IDNIH-11012305 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV who also struggle with opioid use disorder.

Less likely to help

Patients who do not have HIV or opioid use disorder may not benefit from this research.

What this research studies

This research investigates how morphine and HIV proteins affect brain function and behavior, particularly in individuals with opioid use disorder (OUD) and HIV. The study focuses on understanding the impact of these substances on mitochondrial function and brain-derived neurotrophic factor (BDNF) levels, which are crucial for brain health. By using animal models, the research aims to uncover the combined effects of these factors on behaviors that are relevant to human health outcomes. The findings could lead to improved treatment strategies for those suffering from both OUD and HIV.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for individuals with opioid use disorder and HIV, potentially improving their mental and physical health.

How similar studies have gone: Other research has shown promising results in understanding the interactions between opioids and HIV, but this specific approach is relatively novel.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Mclaughlin, Jay P. — University of Florida
  • Study coordinator: Mclaughlin, Jay P.

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.